This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

ACETO Reports Fiscal 2013 Second Quarter Results

CONFERENCE CALL

Salvatore Guccione, Ronald Gold, and Douglas Roth will conduct a conference call at 9:00 a.m. ET on February 8, 2013 to discuss the operating results for the fiscal 2013 second quarter. Interested parties may participate in the call by dialing 888-895-5271 (847-619-6547 for international callers) – please call in 10 minutes before the call is scheduled to begin, and ask for the ACETO call (conference ID # 34143032). The conference call will also be webcast live via the Investor Relations section of our website, www.aceto.com . To listen to the live call please go to the website at least 15 minutes early to register, download and install any necessary audio software. The conference call will be archived on the Company's website, and a recorded phone replay will also be available from 1:00 p.m. ET on Friday, February 8, 2013 until 5:00 p.m. ET on Monday, February 11, 2013. Dial 888-843-7419 (630-652-3042 for international callers) and enter the code 34143032 for the phone replay.

ABOUT ACETO

ACETO Corporation, incorporated in 1947, is a global leader in the marketing, sale and distribution of products for Human Health (finished dosage form generics and nutraceutical products), Pharmaceutical Ingredients (pharmaceutical intermediates and active pharmaceutical ingredients) and Performance Chemicals (specialty chemicals and agricultural protection products). With business operations in nine countries, ACETO distributes over 1,100 chemical compounds used principally as finished products or raw materials in the pharmaceutical, nutraceutical, agricultural, coatings and industrial chemical industries. ACETO's global operations, including a staff of 26 in China and 12 in India, are distinctive in the industry and enable its worldwide sourcing and regulatory capabilities.

The ACETO Corporation logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=13058

FORWARD LOOKING STATEMENTS

This news release contains forward-looking statements as that term is defined in the federal securities laws. The events described in forward-looking statements contained in this news release may not occur. Generally, these statements relate to our business plans or strategies, projected or anticipated benefits or other consequences of ACETO's plans or strategies, financing plans, projected or anticipated benefits from acquisitions that ACETO may make, or a projection involving anticipated revenues, earnings or other aspects of ACETO's operating results or financial position, and the outcome of any contingencies. Any such forward-looking statements are based on current expectations, estimates and projections of management. ACETO intends for these forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements. Words such as "may," "will," "expect," "believe," "anticipate," "project," "plan," "intend," "estimate," and "continue," and their opposites and similar expressions are intended to identify forward-looking statements. The forward-looking statements contained in this press release include, but are not limited to, statements regarding the Company's strategic initiatives including selling finished dosage form generic drugs, and statements regarding the prospects for long-term growth. ACETO cautions you that these statements are not guarantees of future performance or events and are subject to a number of uncertainties, risks and other influences, many of which are beyond ACETO's control, which may influence the accuracy of the statements and the projections upon which the statements are based. Factors that could cause actual results to differ materially from those set forth or implied by any forward-looking statement include, but are not limited to, risks and uncertainties discussed in ACETO's reports filed with the Securities and Exchange Commission, including, but not limited to, ACETO's Annual Report or Form 10-K for the fiscal year ended June 30, 2012 and other filings. Copies of these filings are available at www.sec.gov.

Any one or more of these uncertainties, risks and other influences could materially affect ACETO's results of operations and whether forward-looking statements made by ACETO ultimately prove to be accurate. ACETO's actual results, performance and achievements could differ materially from those expressed or implied in these forward-looking statements. ACETO undertakes no obligation to publicly update or revise any forward-looking statements, whether from new information, future events or otherwise.

         
ACETO Corporation and Subsidiaries    
Consolidated Statements of Income    
(in thousands, except per share amounts)    
         
         
  (unaudited) (unaudited)
  Three Months Ended Six Months Ended
  December 31, December 31,
  2012 2011 2012 2011
Net sales  $ 113,956  $ 110,707  $ 225,704  $ 212,024
Cost of sales  93,248  90,063  183,491  172,861
Gross profit  20,708  20,644  42,213  39,163
Gross profit % 18.17% 18.65% 18.70% 18.47%
         
Selling, general and administrative expenses  14,096  13,528  27,988  27,097
Operating income  6,612  7,116  14,225  12,066
         
Other income (expense), net of interest expense  486  48  495  (163)
         
Income before income taxes  7,098  7,164  14,720  11,903
Income tax provision  2,585  2,576  5,387  4,282
Net income  $ 4,513  $ 4,588  $ 9,333  $ 7,621
         
Net income per common share  $ 0.17  $ 0.17  $ 0.35  $ 0.29
         
Diluted net income per common share  $ 0.17  $ 0.17  $ 0.34  $ 0.29
         
Weighted average shares outstanding:        
Basic  26,959  26,565  26,882  26,520
Diluted  27,316  26,737  27,272  26,686
         
     
ACETO Corporation and Subsidiaries
Consolidated Balance Sheets
(in thousands, except per-share amounts)
     
  December 31, 2012 June 30, 2012
  (unaudited)  
     
Assets    
Current Assets:    
Cash and cash equivalents  $ 25,326  $ 24,862
Investments  1,549  1,518
Trade receivables: less allowances for doubtful accounts: Dec. 31, 2012 $880; and June 30, 2012 $887  77,918  74,744
Other receivables  3,982  2,979
Inventory  97,373  84,687
Prepaid expenses and other current assets  2,314  2,231
Deferred income tax asset, net  1,027  948
     
Total current assets  209,489  191,969
     
     
Property and equipment, net  11,848  11,705
Property held for sale  3,752  3,752
Goodwill  33,541  33,495
Intangible assets, net  42,475  45,251
Deferred income tax asset, net  4,695  4,719
Other assets  9,647  8,389
     
Total Assets  $ 315,447  $ 299,280
     
Liabilities and Shareholders' Equity    
     
Current liabilities:    
Current portion of long-term debt  $ 7,197  $ 6,713
Accounts payable  43,982  42,007
Accrued expenses  26,973  24,921
Total current liabilities  78,152  73,641
     
Long-term debt  40,454  39,052
Long-term liabilities  12,475  12,943
Environmental remediation liability  5,096  5,633
Deferred income tax liability  9  8
Total liabilities  136,186  131,277
     
Commitments and contingencies    
     
Shareholders' equity:    
Common stock, $.01 par value:    
(40,000 shares authorized; 27,297 and 26,937 shares issued and outstanding at Dec. 31, 2012 and June 30, 2012, respectively)  273  269
Capital in excess of par value  66,625  64,071
Retained earnings  108,680  102,344
Accumulated other comprehensive income  3,683  1,319
Total shareholders' equity  179,261  168,003
     
Total liabilities and shareholders' equity  $ 315,447  $ 299,280
     
         
ACETO Corporation
Diluted Net Income Per Common Share Excluding Charges (Non-GAAP Reconciliation)
(in thousands, except per share amounts)
         
  (unaudited) Six Months Ended December 31, 2012 (unaudited) Diluted Net Income Per Common Share Six Months Ended December 31, 2012 (unaudited) Six Months Ended December 31, 2011 (unaudited) Diluted Net Income Per Common Share Six Months Ended December 31, 2011
         
Net income, as reported $9,333  $ 0.34 $7,621  $ 0.29
         
Adjustments:        
Separation charges  --   --   884  0.03
         
Adjusted income excluding charges  9,333 0.34  8,505 0.32
Adjustments to provision for income taxes  --   --   345  0.01
         
Adjusted net income (Non-GAAP)  $ 9,333  $ 0.34  $ 8,160  $ 0.31
         
Diluted weighted average shares outstanding 27,272 27,272 26,686 26,686
         
NOTE: Items identified in the above table are not in accordance with, or an alternative method for, generally accepted accounting principles (GAAP) in the United States. These items should not be reviewed in isolation or considered substitutes of the Company's financial results as reported in accordance with GAAP. Due to the nature of these items, it is important to identify these items and to review them in conjunction with the Company's financial results reported in accordance with GAAP. The exclusion of these items also allows investors to compare results of operations in the current period to prior period's results based on the Company's fundamental business performance and analyze the operating trends of the business. The exclusion of these items also allows management to evaluate performance of its business units.
CONTACT: Investor Relations Contact:
         Amy Glynn
         The Ruth Group
         (646) 536-7023
         aglynn@theruthgroup.com

ACETO Corporation Logo

3 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,880.36 -31.75 -0.19%
S&P 500 1,970.07 +0.12 0.01%
NASDAQ 4,462.9020 +20.2040 0.45%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs